Growth Control of Melanoma Cells and Melanocytes by Cytokines

  • K. Krasagakis
  • C. Garbe
  • Ch. C. Zouboulis
  • C. E. Orfanos
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 139)

Abstract

Aberrant proliferation of tumor cells characterizes cancer growth. Investigations of cellular growth control mechanisms have contributed to our understanding of carcinogenesis and to the identification of compounds with specific antitumor activity. Many cytokines have been found to act on melanoma tumors, either produced by the tumor cells themselves or by infiltrating host cells. Purified cytokines allowed direct comparison of the growth response between normal human melanocytes and malignant melanoma cells. The present paper summarizes results of a series of our own experiments not yet published and data from a review of the recent literature. Proliferation of normal human melanocytes is enhanced by several cytokines, including basic fibroblast growth factor (bFGF), melanoma growth stimulatory activity (MGSA), hepatocyte growth factor (HGF), and mast cell growth factor (MGF). Melanoma cells are additionally stimulated by epidermal growth factor (EGF)/transforming growth factor alpha (TGF-α) and nerve growth factor (NGF). Tumor necrosis factor alpha (TNF-α), transforming growth factor beta 1 (TGF-β 1), and interleukin (IL)-6 are all potent inhibitors of melanocyte growth, but they are less effective on melanoma cells or even stimulate their growth. Interferon (IFN)-α and IFN-γ inhibited proliferation of melanoma cells but not of melanocytes, whereas IFN-β showed antiproliferative effects in both cell types. These findings suggest an alteration in growth control mechanisms during melanocyte transformation and possibly play a role in melanoma pathogenesis.

Keywords

Albumin Tyrosine Hydrocortisone Oncol Polypeptide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albino P, Davis BM, Nanus DM (1991) Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 51:4815–4820PubMedGoogle Scholar
  2. Arita Y, O’Driscoll KR, Weinstein BI (1992) Growth of human melanocyte cultures supported by 12–0-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Cancer Res 52:4514–4521PubMedGoogle Scholar
  3. Becker D, Meier CB, Herlyn M (1989) Proliferation of human malignant melanomas is inhibited by antisense oligonucleotides targeted against basic fibroblast growth factor. EMBO J 8:3685–3691PubMedGoogle Scholar
  4. Becker D, Lee PL, Rodeck U, Herlyn M (1992) Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 7:2303–2313PubMedGoogle Scholar
  5. Bordoni R, Fine R, Murray D, Richmond A (1990) Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J Cell Biochem 44:207–219PubMedCrossRefGoogle Scholar
  6. Carpenter G, Cohen S (1979) Epidermal growth factor. Annu Rev Biochem 48: 193–216PubMedCrossRefGoogle Scholar
  7. Cheifetz S, Weatherbee JA, Tsang ML, Anderson JK, Mole JE, Lucas R, Massague J (1987) The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409–415PubMedCrossRefGoogle Scholar
  8. Chenevix-Trench G, Martin NG, Ellem KAO (1990) Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53. Oncogene 5:1187–1193PubMedGoogle Scholar
  9. Dotto GP, Moelmann G, Ghosh S, Edwards M, Halaban R (1989) Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous enviroment. J Cell Biol 109:3115–3128PubMedCrossRefGoogle Scholar
  10. Eisinger M, Marco O (1982) Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 79:2018–2022PubMedCrossRefGoogle Scholar
  11. Fabricant RN, DeLarco JE, Todaro GJ (1977) Nerve growth factor receptors on human melanoma cells in culture. Proc Natl Acad Sci USA 74:565–569PubMedCrossRefGoogle Scholar
  12. Fisher PB, Miranda AF, Babiss LE (1986) Measurement of the effect of interferons on cellular differentiation in murine and human melanoma cells. Methods Enzymol 119:611–618PubMedCrossRefGoogle Scholar
  13. Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y, Halaban R (1992) c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 3:197–209PubMedGoogle Scholar
  14. Garbe C, Krasagakis K, Zouboulis CC, Schröder K, Krüger S, Stadler R, Orfanos CE (1990) Antitumor activities of interferon alpha, beta and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis and immunophenotype. J Invest Dermatol 95:23IS–237SCrossRefGoogle Scholar
  15. Garbe C, Kreuser ED, Zouboulis CC, Stadler R, Orfanos CE (1992) Combined treatment of metastatic melanoma with interferons and cytotoxic drugs. Semin Oncol 19 [Suppl 4]:63–69PubMedGoogle Scholar
  16. Halaban R, Kwon BS, Ghosh S, Delli Bovi P, Baird A (1988a) bFGF as an autocrine growth factor for human melanomas. Oncogene Res 3:177–186PubMedGoogle Scholar
  17. Halaban R, Langdon R, Birchall N, Cuono C, Baird A, Scott G, Moellmann G, McGuire J (1988b) Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 107:1611–1619PubMedCrossRefGoogle Scholar
  18. Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W et al (1992a) Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195–2206PubMedGoogle Scholar
  19. Halaban R, Fan B, Ahn J, Funasaka Y, Gitay Goren H, Neufeld G (1992b) Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J Immunother 12:154–161PubMedCrossRefGoogle Scholar
  20. Herlyn M, Thurin J, Balaban G, Benicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH, Koprowski H (1985) Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45:5670–5676PubMedGoogle Scholar
  21. Herlyn M, Kath R, Williams N, Valyi-Nagy I, Rodeck U (1990) Growth-regulatory factors for normal, premalignant and malignant human cells in vitro. Adv Cancer Res 54:213–234PubMedCrossRefGoogle Scholar
  22. Kim MK, Warren TC, Kimball ES (1985) Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients. J Biol Chem 260:9237–9243PubMedGoogle Scholar
  23. Krasagakis K, Garbe C, Krüger S, Orfanos CE (1991) Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not -alpha or –gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol 97:364–372PubMedCrossRefGoogle Scholar
  24. Krasagakis K, Garbe C, Krüger-Krasagakes S, Orfanos CE (1993) 12–0 tetra-decanoylphorbol-13-acetate not only modulates proliferation rates but also alters antigen expression and LAK-cell susceptibility of normal human melanocytes in vitro. J Invest Dermatol 100:653–659PubMedCrossRefGoogle Scholar
  25. Lawson DH, Thomas HG, Roy RGB, Gordon DS, Chawla RK, Nixon DW, Richmond A (1987) Preparation of a monoclonal antibody to melanoma growth stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells. J Cell Biochem 34:169–185PubMedCrossRefGoogle Scholar
  26. Lu C, Kerbel RS (1993) Interleukin 6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 120:1281–1288PubMedCrossRefGoogle Scholar
  27. Lu C, Vickers MF, Kerbel RS (1992) Interleukin 6: a fibroblast derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 89:9215–9219PubMedCrossRefGoogle Scholar
  28. Mather JP, Sato GH (1979) The growth of mouse melanoma cells in hormone-supplemented, serum-free medium. Exp Cell Res 120:191–200PubMedCrossRefGoogle Scholar
  29. Mooradian DL, Purchio AF, Furcht LT (1990) Differential effects of transforming growth factor β 1 on the growth of poorly and highly metastatic murine melanoma cells. Cancer Res 50:273–277PubMedGoogle Scholar
  30. Mortarini R, Belli F, Parmiani G, Anichini A (1990) Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations. Int J Cancer 45:334–341PubMedCrossRefGoogle Scholar
  31. Nakai S, Mizuno K, Kaneta M, Hirai Y (1988) A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line. Biochem Biophys Res Commun 154:1189–1196PubMedCrossRefGoogle Scholar
  32. Peacocke M, Yaar M, Mansur CP, Chao MV, Gilchrest BA (1988) Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci USA 85:5282–5286PubMedCrossRefGoogle Scholar
  33. Richmond A, Thomas HG (1988) Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem 36:185–198PubMedCrossRefGoogle Scholar
  34. Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, Bordoni R, Francke R, Derynck R (1988) Molecular characterisation and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to β-thromboglobulin. EMBO J 7:2025–2033PubMedGoogle Scholar
  35. Rodeck U, Herlyn, M, Menssen HD, Furlanetto RW, Koprowski H (1987) Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer 40:687–690PubMedCrossRefGoogle Scholar
  36. Rodeck U, Melber K, Kath R, Menssen H-D, Varello M, Atkinson B, Herlyn M (1991) Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97:20–26PubMedCrossRefGoogle Scholar
  37. Sauvaigo S, Fretts RE, Riopelle RJ, Lagard AE (1986) Autonomous proliferation of MeWo human melanoma cell lines in serum-free medium: secretion of growth-stimulating activities. Int J Cancer 37:123–132PubMedCrossRefGoogle Scholar
  38. Schadendorf D, Möller A, Algermissen B, Worm M, Sticherling M, Czarniecki BM (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151:2667–2675PubMedGoogle Scholar
  39. Sun WH, Kreisle RA, Phillips AW, Ershler WB (1992) In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res 52:5412–5415PubMedGoogle Scholar
  40. Swope VB, Abdel-Malek Z, Kassem LM, Nordlund JJ (1991) Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 96:180–185PubMedCrossRefGoogle Scholar
  41. Todaro GJ (1988) Oncogenes and growth factors. In: Orfanos CE, Stadler R, Gollnick H (eds) Dermatology in five continents. Springer, Berlin Heidelberg New York, pp 11–25Google Scholar
  42. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC (1992) Nonhematopoietic tumor cells express stem cell factor and display c-kit receptors. Blood 80:374–381PubMedGoogle Scholar
  43. Tyring SK, Klimpel G, Brysk M (1984) Eradication of cultured human melanoma cells by immune interferon and leukocytes. J Natl Cancer Inst 73:1067–1073PubMedGoogle Scholar
  44. Wadler S, Schwartz EL (1990) Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 50:3473–3486PubMedGoogle Scholar
  45. Zouboulis CC, Garbe C, Krüger S, Orfanos CE (1990a) Interferons and melanoma: comparison of the cytostatic and cytotoxic effects of natural and recombinant interferons, tumor necrosis factor-alpha and their combinations on human melanoma cells in vitro. Skin Cancer 5:137–145Google Scholar
  46. Zouboulis CC, Schröder K, Garbe C, Krasagakis K, Krüger S, Orfanos CE (1990b) Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-alpha on sensitive human melanoma cells in vitro may result in selection of cells with enhanced markers of malignancy. J Invest Dermatol 95:223S–230SPubMedCrossRefGoogle Scholar
  47. Zouboulis CC, Garbe C, Krasagakis K, Krüger S, Orfanos CE (1991) A fluorometric rapid microassay to identify antiproliferative compounds for human melanoma cells in vitro. Melanoma Res 1:91–95PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1995

Authors and Affiliations

  • K. Krasagakis
    • 1
  • C. Garbe
    • 1
  • Ch. C. Zouboulis
    • 1
  • C. E. Orfanos
    • 1
  1. 1.Department of Dermatology, University Medical Center SteglitzThe Free University of BerlinBerlinGermany

Personalised recommendations